Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FFAR3 | O14843 | 2/20 | 1.00 |
| ▸ | TDP1 | Q9NUW8 | 4/20 | 0.54 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.54 |
| ▸ | HDAC3 | O15379 | 1/20 | 0.53 |
| ▸ | HDAC1 | Q13547 | 1/20 | 0.53 |
| ▸ | HDAC2 | Q92769 | 1/20 | 0.53 |
| ▸ | HDAC8 | Q9BY41 | 1/20 | 0.53 |
| ▸ | LDHA | P00338 | 1/20 | 0.46 |
| ▸ | SRR | Q9GZT4 | 1/20 | 0.46 |
| ▸ | LMNA | P02545 | 1/20 | 0.46 |
| ▸ | ALKBH5 | Q6P6C2 | 1/20 | 0.46 |
| ▸ | SUCNR1 | Q9BXA5 | 1/20 | 0.46 |
| ▸ | EGLN1 | Q9GZT9 | 1/20 | 0.46 |
| ▸ | AKR1B1 | P15121 | 1/20 | 0.44 |
| ▸ | TSHR | P16473 | 6/20 | 0.43 |
| ▸ | OR51E2 | Q9H255 | 2/20 | 0.43 |
| ▸ | GLRA1 | P23415 | 1/20 | 0.43 |
| ▸ | SLC6A9 | P48067 | 1/20 | 0.43 |
| ▸ | PPARG | P37231 | 6/20 | 0.42 |
| ▸ | PPARD | Q03181 | 6/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Propionic Acid SCHEMBL7102943 | 1.00 | — | — | |
| Propionic Acid SCHEMBL11661434 | 1.00 | FFAR3 (1.00) | FFAR3TDP1ALDH1A1HDAC3HDAC1 | |
| Propionic Acid SCHEMBL11176741 | 1.00 | — | — | |
| Propionic Acid SCHEMBL19409 | 1.00 | FFAR3 (1.00) | FFAR3TDP1ALDH1A1HDAC3HDAC1 | |
| Propionic Acid SCHEMBL1331605 | 1.00 | — | — | |
| Propionic Acid SCHEMBL1332599 | 1.00 | — | — | |
| Propionic Acid SCHEMBL290 | 1.00 | — | — | |
| Propionic Acid SCHEMBL1331656 | 1.00 | — | — | |
| Propionic Acid SCHEMBL1462509 | 1.00 | FFAR3 (1.00) | FFAR3TDP1ALDH1A1HDAC3HDAC1 | |
| Propionic Acid SCHEMBL25298543 | 0.95 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 19 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-112940248-B | PH responsive metal coordination polymer prodrug nano-particle and preparation method thereof | 西安交通大学 | 2023-07-18 | — | — | CN | disclosed |
| US-11623912-B2 | Triesters of cyclohexanetripropionic acid | EVONIK OPERATIONS GMBH (DE) | 2023-04-11 | — | — | US | disclosed |
| US-20210179534-A1 | TRIESTERS OF CYCLOHEXANETRIPROPIONIC ACID | EVONIK OPERATIONS GMBH (DE) | 2021-06-17 | — | — | US | disclosed |
| CN-112940248-A | PH-responsive metal coordination poly-prodrug nanoparticles and preparation method thereof | 西安交通大学 | 2021-06-11 | — | — | CN | disclosed |
| CN-112204000-A | Novel crop nutrition and fortification compositions | 阿鲁恩·维塔尔·沙旺特 | 2021-01-08 | — | — | CN | disclosed |
| CN-111741754-A | Deuterated compounds as immunomodulators | 凯莫森特里克斯股份有限公司 | 2020-10-02 | — | — | CN | disclosed |
| CN-110036056-A | Quaternary cation polymer | 埃科莱布美国股份有限公司 | 2019-07-19 | — | — | CN | disclosed |
| CN-109642331-A | For alleviating the benzotriazole and tolytriazole derivative of corrosion | 艺康美国股份有限公司 | 2019-04-16 | — | — | CN | disclosed |
| CN-108697713-A | Methods for making tricyclic PI3K inhibitor compounds and methods of treating cancer therewith | 基因泰克公司 | 2018-10-23 | — | — | CN | disclosed |
| CN-104558083-B | A kind of synthetic method of beclomethasone dipropionate organic solvent-free | 天津金耀集团有限公司 | 2018-08-31 | — | — | CN | disclosed |
| CN-104558082-B | A kind of synthetic method of BD | 天津金耀集团有限公司 | 2018-01-23 | — | — | CN | disclosed |
| CN-107406909-A | Leaching agent for metal recovery | 艺康美国股份有限公司 | 2017-11-28 | — | — | CN | disclosed |
| CN-104558083-A | Synthetic method of beclomethasone dipropionate organic-free solvent | TIANJIN JINYAO GROUP CO LTD | 2015-04-29 | — | — | CN | disclosed |
| CN-104558082-A | Synthetic method of beclomethasone dipropionate | TIANJIN JINYAO GROUP CO LTD | 2015-04-29 | — | — | CN | disclosed |
| WO-2003086348-A1 | ALLERGIC DERMATITIS FORMULATION AND METHOD OF TREATMENT | DERMCARE-VET PTY LTD (AU) | 2003-10-23 | — | — | WO | disclosed |
| US-5278279-A | Polymerization in presence of an organic phosphorus compound | DAICEL CHEMICAL INDUSTRIES, LTD. (JP) | 1994-01-11 | — | — | US | disclosed |
| EP-0000609-B1 | NOVEL 19-NOR-PREGNAHEXAENES, PROCESS FOR THE PREPARATION THEREOF, AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM | Technobiotic Ltd. (CH) | 1981-09-23 | — | — | EP | disclosed |
| US-4201778-A | 6-Acyloxy-1,4,6-pregnatrienes, their use as anti-inflammatory agents, methods for their manufacture, and 6-oxo-1,4-pregnadiene intermediates | SCHERING CORPORATION (US) | 1980-05-06 | — | — | US | disclosed |
| EP-0001864-A1 | Novel 6-oxygenated-3,20-dioxo-pregnane derivatives, process for the preparation thereof, and pharmaceutical compositions containing them | Technobiotic Ltd. (CH) | 1979-05-16 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20210179534-A1 | TRIESTERS OF CYCLOHEXANETRIPROPIONIC ACID | HPD, HCAR2, HCAR3 | FFAR3 212/4885TDP1 1641/4885ALDH1A1 661/4885 |
| US-11623912-B2 | Triesters of cyclohexanetripropionic acid | NMUR1, NT5M, NIT2 | FFAR3 263/4885TDP1 233/4885ALDH1A1 1058/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.